video corpo

LT367 FH Array Brochure
1 / 4Páginas

Excertos do catálogo

LT367 FH Array Brochure - 1

Familial Hypercholesterolaemia (FH) Arrays Rapid and reliable genetic assessment of patients with suspected FH

Abrir o catálogo na página 1
LT367 FH Array Brochure - 2

Familial Hypercholesterolaemia (FH) Arrays I & II Rapid, simultaneous detection of 40 mutations within the LDLR, ApoB and PCSK9 genes Introduction Familial Hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism. It is a common autosomal dominant, or inherited, disease which affects the plasma clearance of LDL-cholesterol (LDL-C), resulting in premature onset of cardiovascular disease (CVD) and a higher mortality risk.1-3 Common genetic defects in FH are attributed to mutations in three genes encoding proteins involved in the uptake of LDL-C from the plasma: the low...

Abrir o catálogo na página 2
LT367 FH Array Brochure - 3

Analyte Name Analyte Name FH Arrays I & II protocol Extraction Genomic DNA extracted from blood Amplicon hybridisation/ conjugation to biochip array results processing by Evidence Investigator analyser Benefits of the Randox Familial Hypercholesterolaemia (FH) Arrays I & II Product features • Rapid turnaround time of ~3 hours from extracted genomic DNA to result • Samples can be assessed in small batches (as few as 3 samples) with only 20ng of genomic DNA required per array Benefits to the laboratory • Developed with leading experts to test for 40 specific FH-causing mutations with ~78%...

Abrir o catálogo na página 3
LT367 FH Array Brochure - 4

PRECISE DIAGNOSTICS FOR TARGETED THERAPY Understanding drivers of disease is vital in delivering effective patient care. Through the unravelling of the genetic code, healthcare practitioners are able to predict and prevent disease and prescribe appropriate targeted treatments to specific subgroups, for optimal patient outcomes. Randox Molecular offers a range of assay formats including SNP genotyping, gene expression, pathogen detection and mutation detection across infectious diseases, cardiovascular disease and oncology. Utilising innovative Biochip Array Technology (BAT) for...

Abrir o catálogo na página 4

Todos os catálogos e folhetos técnicos Randox Laboratories

  1. Acusera 24.7

    24 Páginas

  2. Company Overview

    40 Páginas

  3. Reagents Brochure

    64 Páginas

  4. sdLDL-C

    8 Páginas

  5. RX modena

    20 Páginas

  6. RX misano

    20 Páginas

  7. RX Daytona Plus

    20 Páginas

  8. Rx Imola

    20 Páginas

  9. RX Monaco

    20 Páginas

  10. 2024 Product List

    64 Páginas

  11. VeraSTAT-V

    16 Páginas

  12. VERASTAT

    16 Páginas

  13. Endocrine Array

    4 Páginas

  14. Cerebral Arrays

    4 Páginas

  15. Thyroid Arrays

    4 Páginas

  16. Basic QC Stastics

    8 Páginas

  17. Qnostics

    52 Páginas

  18. Adiponectin LT519

    28 Páginas

  19. Specific Proteins

    40 Páginas

  20. Linearity sets

    12 Páginas

  21. Antioxidants

    16 Páginas

  22. Diabetes Portfolio

    28 Páginas

  23. Total Bile Acids

    4 Páginas

  24. VIVALYTIC

    30 Páginas

  25. RANDOX DISCOVERY

    36 Páginas

  26. HbA1c

    2 Páginas

  27. Preparing QC

    1 Páginas

Catálogos arquivados

  1. ACUSERA

    108 Páginas

  2. Evidence Evolution

    28 Páginas

  3. Evidence

    16 Páginas

  4. Molecular Testing

    16 Páginas

  5. Fertility Array

    4 Páginas

  6. Rx Daytona

    16 Páginas

  7. Evidence

    16 Páginas